Geriatric care for LGBTQ+ adults who live in rural communities requires cultural competence training and diverse health care teams.

The FDA has issued a Complete Response Letter regarding the NDA for govorestat for the treatment of classic galactosemia.

About one-third of US adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 (GLP-1) receptor agonists and GLP-1/glucose-dependent insulinotropic polypeptide ...

For low-risk pregnancies, planned home births are as safe as planned birth center births, according to a study published.

Long-term sex hormone treatment in transgender individuals can lead to significant changes in body composition and risk factors for cardiovascular disease.

Denifanstat treatment significantly improves liver disease activity among individuals with metabolic dysfunction-associated steatohepatitis.

Diabetic retinopathy screening with AI was associated with higher referral rates to optical coherence tomography but remains underutilized.

Current prenatal multivitamin and mineral (PMVM) labels are misleading and often exclude the presence of heavy metals.

Heart failure outcomes in patients with type 2 diabetes receiving once-weekly exenatide are affected by left ventricular ejection fraction.

The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.

President-elect Donald Trump has tapped Dr. Jay Bhattacharya, a Stanford health economist and critic of pandemic lockdowns and vaccine mandates, to lead the nation's largest medical research agency, ...

Lower noninvasive test cut-points are recommended among Hispanic adults with MASLD in order to optimize surveillance of fibrosis.